Published in Steroids on November 23, 2012
Vitamin D: a critical and essential micronutrient for human health. Front Physiol (2014) 1.05
Patterns of genome-wide VDR locations. PLoS One (2014) 1.01
Primary vitamin D target genes allow a categorization of possible benefits of vitamin D₃ supplementation. PLoS One (2013) 0.95
Mechanisms of osteoclast-dependent bone formation. Bonekey Rep (2013) 0.94
Genome-wide (over)view on the actions of vitamin D. Front Physiol (2014) 0.93
Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells. Cancers (Basel) (2013) 0.93
IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis (2014) 0.92
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91
A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children. BMC Genomics (2013) 0.90
Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells. PLoS One (2013) 0.89
Vitamin D and the RNA transcriptome: more than mRNA regulation. Front Physiol (2014) 0.88
Caenorhabditis elegans metabolic gene regulatory networks govern the cellular economy. Trends Endocrinol Metab (2014) 0.85
Regulation of Dendritic Cell Function by Vitamin D. Nutrients (2015) 0.84
Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities. Pain Res Treat (2015) 0.83
Vitamin D and microRNAs in bone. Crit Rev Eukaryot Gene Expr (2013) 0.83
Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model. Oncotarget (2014) 0.81
Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening. PLoS One (2014) 0.81
The heterodimeric structure of heterogeneous nuclear ribonucleoprotein C1/C2 dictates 1,25-dihydroxyvitamin D-directed transcriptional events in osteoblasts. Bone Res (2014) 0.81
Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection. Hepat Mon (2015) 0.80
Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther (2014) 0.80
Vitamin D and alternative splicing of RNA. J Steroid Biochem Mol Biol (2014) 0.78
Vitamin D and the Epithelial to Mesenchymal Transition. Stem Cells Int (2016) 0.78
Relevance of vitamin D receptor target genes for monitoring the vitamin D responsiveness of primary human cells. PLoS One (2015) 0.77
Alterations in vitamin D signaling pathway in gastric cancer progression: a study of vitamin D receptor expression in human normal, premalignant, and malignant gastric tissue. Int J Clin Exp Pathol (2015) 0.77
VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription. Epigenetics (2015) 0.77
Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions. Nucl Receptor Res (2016) 0.77
Immune Response Modulation by Vitamin D: Role in Systemic Lupus Erythematosus. Front Immunol (2015) 0.76
Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF. Nucleic Acids Res (2015) 0.76
Vitamin D receptor and RXR in the post-genomic era. J Cell Physiol (2015) 0.76
Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes. BMC Genomics (2017) 0.76
Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes. Oncotarget (2016) 0.76
Gene regulatory scenarios of primary 1,25-dihydroxyvitamin d3 target genes in a human myeloid leukemia cell line. Cancers (Basel) (2013) 0.76
25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃. Int J Mol Sci (2016) 0.75
Identification of vitamin D sensitive pathways during lung development. Respir Res (2016) 0.75
Microarray‑based screening of differentially expressed genes in glucocorticoid‑induced avascular necrosis. Mol Med Rep (2017) 0.75
The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. Oncotarget (2017) 0.75
Inherited Variation in Vitamin D Genes and Type 1 Diabetes Predisposition. Genes (Basel) (2017) 0.75
A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease. J Alzheimers Dis (2016) 0.75
Cord blood vitamin D status and neonatal outcomes in a birth cohort in Quebec, Canada. Arch Gynecol Obstet (2015) 0.75
Vitamin D—update for the pediatric rheumatologists. Pediatr Rheumatol Online J (2015) 0.75
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Vitamin D deficiency. N Engl J Med (2007) 59.34
RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 58.77
Translating the histone code. Science (2001) 56.77
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 20.59
Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet (2003) 14.56
An oestrogen-receptor-alpha-bound human chromatin interactome. Nature (2009) 12.16
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell (2000) 11.10
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell (2003) 10.42
Cooperation between complexes that regulate chromatin structure and transcription. Cell (2002) 10.38
A census of human transcription factors: function, expression and evolution. Nat Rev Genet (2009) 9.19
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell (1991) 8.85
Nuclear receptors and lipid physiology: opening the X-files. Science (2001) 8.76
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr (2004) 8.48
Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell (2011) 7.03
Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science (2009) 6.07
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
Pioneer transcription factors: establishing competence for gene expression. Genes Dev (2011) 6.01
Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr (2004) 5.88
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature (2012) 5.84
MicroRNA control of signal transduction. Nat Rev Mol Cell Biol (2010) 5.74
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J (2009) 5.36
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Gene regulation by transcription factors and microRNAs. Science (2008) 5.07
Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev (2008) 4.93
Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev (1999) 4.92
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res (2010) 4.77
CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J (1998) 4.61
Nuclear hormone receptors and gene expression. Physiol Rev (2001) 4.56
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature (1999) 4.40
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell (2007) 4.33
Current understanding of the molecular actions of vitamin D. Physiol Rev (1998) 4.05
Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci (2000) 3.77
Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A (1988) 3.53
Vitamin D: modulator of the immune system. Curr Opin Pharmacol (2010) 3.31
Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet (2010) 3.29
Two nuclear signalling pathways for vitamin D. Nature (1993) 3.12
Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc Natl Acad Sci U S A (1993) 3.09
The SRC family of nuclear receptor coactivators. Gene (2000) 2.96
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol (2005) 2.73
Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell (1990) 2.68
Spreading of silent chromatin: inaction at a distance. Nat Rev Genet (2006) 2.64
Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet (2009) 2.57
Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev (2009) 2.47
Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol (2009) 2.46
Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci (2004) 2.24
p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol (2008) 2.04
Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep (2006) 1.94
Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc Natl Acad Sci U S A (2002) 1.93
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res (2004) 1.90
Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem (2002) 1.90
Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res (2006) 1.89
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Vitamin D: a pleiotropic hormone. Kidney Int (2010) 1.76
The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays (2009) 1.72
Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol (2003) 1.69
Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol (2011) 1.67
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab (2011) 1.66
Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. J Mol Biol (2005) 1.64
Dynamics of nuclear receptor target gene regulation. Chromosoma (2010) 1.63
The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol (1997) 1.53
VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J (2000) 1.52
Co-repressors 2000. FASEB J (2000) 1.48
Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat (2003) 1.47
VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol Endocrinol (2011) 1.46
Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res (2003) 1.46
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res (2009) 1.43
Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res (2011) 1.38
Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol (2009) 1.35
Retracted Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J (2004) 1.35
MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle (2009) 1.33
Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J Biol Chem (2009) 1.28
Nuclear receptors and chromatin remodeling machinery. Mol Cell Endocrinol (2007) 1.28
Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Expr (1998) 1.28
Hematopoietic developmental pathways: on cellular basis. Oncogene (2007) 1.28
Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta (2004) 1.20
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene (2004) 1.20
Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer (2011) 1.20
Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Nucleic Acids Res (2005) 1.18
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate (2004) 1.17
Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands. Proc Natl Acad Sci U S A (1975) 1.16
Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res (2007) 1.14
Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med (2008) 1.12
Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res (2005) 1.10
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. Cancer Res (2005) 1.08
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07
Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene. Biochim Biophys Acta (2007) 1.06
Studies on calciferol metabolism. 8. Evidence for a cytoplasmic receptor for 1,25-dihydroxy-vitamin D3 in the intestinal mucosa. J Biol Chem (1973) 1.05
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res (2010) 1.03
Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. J Steroid Biochem Mol Biol (2004) 1.02
The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res (2012) 1.01
Primary effect of 1α,25(OH)₂D₃ on IL-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta (2010) 0.98
Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res (2006) 1.89
Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res (2005) 1.58
Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol (2005) 1.45
Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food (2004) 1.26
The vitamin D receptor in cancer. Proc Nutr Soc (2008) 1.22
Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res (2006) 1.22
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene (2004) 1.20
KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet (2011) 1.10
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs (2005) 1.06
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res (2010) 1.03
Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Res (2010) 1.02
Identification of VDR-responsive gene signatures in breast cancer cells. Oncology (2007) 0.99
Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle (2012) 0.99
Transcription factor co-repressors in cancer biology: roles and targeting. Int J Cancer (2010) 0.98
Transcription factors, chromatin and cancer. Int J Biochem Cell Biol (2008) 0.97
Vitamin D status and breast cancer risk. Anticancer Res (2006) 0.95
Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis (2010) 0.95
Epigenetic corruption of VDR signalling in malignancy. Anticancer Res (2006) 0.95
Primary vitamin D target genes allow a categorization of possible benefits of vitamin D₃ supplementation. PLoS One (2013) 0.95
Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells. J Steroid Biochem Mol Biol (2006) 0.94
Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis (2009) 0.94
Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation. Recent Results Cancer Res (2003) 0.94
Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Carcinogenesis (2012) 0.91
Met receptor signaling: a key effector in esophageal adenocarcinoma. Clin Cancer Res (2006) 0.89
Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients. Oncotarget (2014) 0.89
Design principles of nuclear receptor signaling: how complex networking improves signal transduction. Mol Syst Biol (2010) 0.88
Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. J Steroid Biochem Mol Biol (2004) 0.87
Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells. PLoS One (2011) 0.86
Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells. J Steroid Biochem Mol Biol (2012) 0.84
The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer. Cancers (Basel) (2013) 0.81
Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells. Mol Cell Endocrinol (2004) 0.79
Epigenetic repression of transcription by the Vitamin D3 receptor in prostate cancer cells. J Steroid Biochem Mol Biol (2004) 0.79
Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer. Carcinogenesis (2013) 0.78
VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription. Epigenetics (2015) 0.77
Gene regulatory scenarios of primary 1,25-dihydroxyvitamin d3 target genes in a human myeloid leukemia cell line. Cancers (Basel) (2013) 0.76
Regulation of CYP3A4 and CYP3A5 expression and modulation of "intracrine" metabolism of androgens in prostate cells by liganded vitamin D receptor. Mol Cell Endocrinol (2012) 0.76
Vitamin D receptor and RXR in the post-genomic era. J Cell Physiol (2015) 0.76
Vitamin D and p53—differentiating their relationship in AML. Cancer Biol Ther (2010) 0.75